InvestorsHub Logo
Followers 4048
Posts 152463
Boards Moderated 3
Alias Born 08/05/2009

Re: Gls3ms post# 132023

Monday, 04/27/2020 4:49:48 PM

Monday, April 27, 2020 4:49:48 PM

Post# of 183227

If our own proprietary SARS-CoV-2 Virus-Like Particle (“VLP”) program, IBIO-200, results in an approved vaccine, we estimate that we could make about 500 million doses of high-quality product annually at our Texas facility, depending upon the potency we see in the clinic,” said Tom Isett, Co-Chairman & CEO of iBio.




http://www.globenewswire.com/news-release/2020/04/27/2022802/0/en/iBio-Estimates-500-Million-Dose-Capacity-for-COVID-19-Vaccine-from-its-FastPharming-Facility.html


sorry thats NOT Press Release worthy


thats a what IF




IBIO

#FAKENEWS
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.